PatientsVille.com Logo

PatientsVille

Potassium Side Effects

Common Potassium Side Effects

The most commonly reported Potassium side effects (click to view or check a box to report):

Hyperkalaemia (64)
Nausea (46)
Pain (45)
Dyspnoea (43)
Dizziness (42)
Asthenia (41)
Fatigue (37)
Cardiac Arrest (34)
Diarrhoea (32)
Completed Suicide (29)
Renal Failure (28)
Vomiting (28)
Oedema Peripheral (27)
Anxiety (26)
Chest Pain (26)
Pain In Extremity (25)
Muscle Spasms (25)
Fall (24)
Death (24)
Pyrexia (23)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Potassium Side Effects Reported to FDA

The following Potassium reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Potassium on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Flatulence, Abdominal Distension, Local Swelling, Product Substitution Issue, Product Coating Issue
on Mar 10, 2014 Female from US , 77 years of age, weighting 140.0 lb, was diagnosed with and was treated with Potassium Chloride. Directly after, patient experienced the unwanted or unexpected Potassium side effects: flatulence, abdominal distension, local swelling, product substitution issue, product coating issue. Potassium Chloride dosage: 10 Tbcr?1 Pill Twice Daily?twice Daily ?by Mouth, After Food With 8ozs. Ivater. Patient was hospitalized and became disabled.

Amniotic Cavity Infection, Tachycardia, Body Temperature Increased, Premature Labour, Premature Rupture Of Membranes, Breech Presentation, Maternal Exposure During Pregnancy
Patient was taking Potassium Chloride. Patient felt the following Potassium side effects: amniotic cavity infection, tachycardia, body temperature increased, premature labour, premature rupture of membranes, breech presentation, maternal exposure during pregnancy on Mar 07, 2014 from US Additional patient health information: Female , 18 years of age, . Potassium Chloride dosage: N/A.
Multiple prescriptions taken:
  • Doxycycline (200 Mg, Every 12 Hours)
  • Ticarcillin (3.1 G, Every 6 Hours)
  • Clavulanate Potassium
  • Oxytocin


Unresponsive To Stimuli, Cardio-respiratory Arrest, Pulseless Electrical Activity, Alkalosis, Acidosis, Hyperkalaemia
Adverse event was reported on Mar 06, 2014 by a Male taking Potassium Chloride (Dosage: N/A) was diagnosed with and. Location: US , 68 years of age, weighting 121.3 lb, After Potassium was administered, patient encountered several Potassium side effects: unresponsive to stimuli, cardio-respiratory arrest, pulseless electrical activity, alkalosis, acidosis, hyperkalaemia.

Pulseless Electrical Activity, Cardiac Arrest, Hyperkalaemia, Bradycardia
on Mar 05, 2014 Female from US , 85 years of age, weighting 103.0 lb, was diagnosed with and was treated with Potassium Chloride. Directly after, patient experienced the unwanted or unexpected Potassium side effects: pulseless electrical activity, cardiac arrest, hyperkalaemia, bradycardia. Potassium Chloride dosage: 5 Packages Of 20 Meq; J-tube (jejunostomy Tube). Patient was hospitalized.


Abdominal Pain Upper, Nausea
on Mar 04, 2014 Female from COUNTRY NOT SPECIFIED , 61 years of age, was treated with Potassium. Patient felt the following Potassium side effects: abdominal pain upper, nausea. Potassium dosage: 20 Meq 2 Packets Once A Day.
Multiple prescriptions taken:
  • Prednisone (5mg 4 Tablets Once A Day)
  • Propranolol (20mg 1 Tablet Twice A Day)
  • Metronidazole
  • Lipitor
  • Metoprolol
  • Humira
  • Lansoprazole (30mg 2 Tablets Once A Day)
  • Mesalamine (250mg 4 Capsules Three Times A Day)


Product Quality Issue, Throat Irritation, Amnesia
Patient was taking Potassium Cl. After Potassium was administered, patient encountered several Potassium side effects: product quality issue, throat irritation, amnesia on Feb 25, 2014 from US Additional patient health information: Female , 81 years of age, weighting 132.0 lb, was diagnosed with and. Potassium Cl dosage: 2 Caps Once Daily (with Food) By Mouth ( 1 Take It With Breaksast)(including Hot Coffee).
Multiple concurrent drugs taken:
  • Omeprazole
  • Diphenoxylate/atropine
  • Furosemide
  • Glucosamine
  • Multivitamin
  • B-complex
  • Fish Oil
  • Calcium


Blister, Skin Lesion
Adverse event was reported on Feb 25, 2014 by a Male taking Potassium Chloride Oral Solution .10 (Dosage: 10%, 3.75ml (5meq) Diluted In 10ml Of Water) . Location: US , child 12 years of age, Directly after, patient experienced the unwanted or unexpected Potassium side effects: blister, skin lesion.

Hyperkalaemia
on Feb 19, 2014 Male from US , 90 years of age, was diagnosed with and was treated with Potassium Chloride. Patient felt the following Potassium side effects: hyperkalaemia. Potassium Chloride dosage: 1 Pill Qd Oral.
Multiple prescriptions taken:
  • Aspirin
  • Atenolol
  • Oyster Shell Calcium-vitamin D3
Patient was hospitalized.

Large Intestinal Obstruction, Product Substitution Issue
on Jan 16, 2014 Female from US , 86 years of age, was treated with Potassium. After Potassium was administered, patient encountered several Potassium side effects: large intestinal obstruction, product substitution issue. Potassium dosage: 1 Tablet.
Multiple concurrent drugs taken:
  • Matopalon
  • Adver
  • Spanva


Pain, Joint Swelling, Abasia, Sensation Of Heaviness, Local Swelling
Patient was taking Potassium. Directly after, patient experienced the unwanted or unexpected Potassium side effects: pain, joint swelling, abasia, sensation of heaviness, local swelling on Jan 14, 2014 from US Additional patient health information: Female , weighting 155.0 lb, . Potassium dosage: 10 Nieq 2 Pills Twice Daily By Mouth.
Associated medications used:
  • Hydrochorothiazide
  • Oyster Shell
  • Alendronate Sodium
  • Naproxen Pain + Fever
Patient was hospitalized and became disabled.

Hyperkalaemia
Adverse event was reported on Jan 09, 2014 by a Male taking Potassium Chloride (Dosage: 20 Meq Bid Po) was diagnosed with and. Location: US , 61 years of age, weighting 144.2 lb, Patient felt the following Potassium side effects: hyperkalaemia.
Multiple prescriptions taken:
  • Spironolactone
Patient was hospitalized.

Device Occlusion, Device Alarm Issue, No Adverse Event
on Dec 27, 2013 Female from US , child 4 years of age, was treated with Potassium Chloride In Sodium Chloride. After Potassium was administered, patient encountered several Potassium side effects: device occlusion, device alarm issue, no adverse event. Potassium Chloride In Sodium Chloride dosage: N/A.
Multiple concurrent drugs taken:
  • Dextrose
  • Ketamine
  • Dilaudid


Hypersensitivity
on Dec 05, 2013 Female from US , 66 years of age, was treated with Potassium Chloride Extended-release (watson Laboratories). Directly after, patient experienced the unwanted or unexpected Potassium side effects: hypersensitivity. Potassium Chloride Extended-release (watson Laboratories) dosage: N/A.

Oral Pain, Excoriation, Laryngeal Disorder, Retching, Oropharyngeal Pain, Product Physical Issue, Product Quality Issue
Patient was taking Potassium Chloride. Patient felt the following Potassium side effects: oral pain, excoriation, laryngeal disorder, retching, oropharyngeal pain, product physical issue, product quality issue on Dec 02, 2013 from US Additional patient health information: Female , 74 years of age, weighting 164.0 lb, was diagnosed with and. Potassium Chloride dosage: N/A.

Hypokalaemia, Fatigue
Adverse event was reported on Jan 24, 2014 by a Male taking Potassium Chloride (Dosage: N/A) . Location: IT , 63 years of age, After Potassium was administered, patient encountered several Potassium side effects: hypokalaemia, fatigue.
Multiple concurrent drugs taken:
  • Ramipril (1 Df, Qd)
  • Kanrenol (200 Mg, Qd)
  • Ferro-grad (105 Mg)
  • Bisoprolol (2.5 Mg)
  • Atorvastatin (20 Mg)
  • Dorzolamide
  • Timolol
  • Insulin Lispro (30 U)
Patient was hospitalized.

Hyperkalaemia, Ventricular Fibrillation, Pulseless Electrical Activity, Electrocardiogram St Segment Elevation, Electrocardiogram Qrs Complex Prolonged, Overdose
on Nov 07, 2013 Male from HU , 56 years of age, was diagnosed with and was treated with Potassium Chloride Extended-release (watson Laboratories). Directly after, patient experienced the unwanted or unexpected Potassium side effects: hyperkalaemia, ventricular fibrillation, pulseless electrical activity, electrocardiogram st segment elevation, electrocardiogram qrs complex prolonged, overdose. Potassium Chloride Extended-release (watson Laboratories) dosage: }50 G, Single. Patient was hospitalized.

Renal Failure
on Oct 31, 2013 Female from US , 70 years of age, weighting 119.0 lb, was diagnosed with and was treated with Potassium Chloride Extended-release (watson Laboratories). Patient felt the following Potassium side effects: renal failure. Potassium Chloride Extended-release (watson Laboratories) dosage: 20 Meq, Bid.
Multiple prescriptions taken:
  • Magnesium (Daily)
  • Neurontin (Daily)
Patient was hospitalized.

Renal Failure, Dehydration
Patient was taking Potassium Chloride. After Potassium was administered, patient encountered several Potassium side effects: renal failure, dehydration on Dec 13, 2013 from US Additional patient health information: Female , 70 years of age, weighting 117.9 lb, . Potassium Chloride dosage: N/A.
Multiple concurrent drugs taken:
  • Magnesium (magnesium)
  • Neurontin (gabapentin)
  • Vitamin D3 (colecalciferol)
Patient was hospitalized.

Extravasation, Skin Necrosis
Adverse event was reported on Oct 22, 2013 by a Female taking Potassium Chloride (Dosage: 1 In 6 Hrs) was diagnosed with and. Location: FR , 56 years of age, Directly after, patient experienced the unwanted or unexpected Potassium side effects: extravasation, skin necrosis. Patient was hospitalized.

Supraventricular Tachycardia, Grand Mal Convulsion, Nodal Rhythm, Pyrexia, Hypotension
on Oct 17, 2013 Patient from US , 54 years of age, was treated with Potassium Chloride In 5% Dextrose And Sodium Chloride Injection , Usp. Patient felt the following Potassium side effects: supraventricular tachycardia, grand mal convulsion, nodal rhythm, pyrexia, hypotension. Potassium Chloride In 5% Dextrose And Sodium Chloride Injection , Usp dosage: N/A.
Multiple prescriptions taken:
  • Levophed
  • Levophed
  • Levophed
  • Aspirin
  • Tylenol


Urticaria, Palpitations, Dysphonia
on Oct 15, 2013 Female from US , 84 years of age, was treated with Potassium Chloride Micro-dispersible. After Potassium was administered, patient encountered several Potassium side effects: urticaria, palpitations, dysphonia. Potassium Chloride Micro-dispersible dosage: 100 Meq, Qd.
Multiple concurrent drugs taken:
  • Xanax (Unk)
  • Vitamin B12 /00056201/ (Unk)
  • Levothyroxine (Unk)
  • Edecrin /00020501/ (Unk)


Product Quality Issue, Product Physical Issue
Patient was taking Potassium. Directly after, patient experienced the unwanted or unexpected Potassium side effects: product quality issue, product physical issue on Sep 24, 2013 from US Additional patient health information: Male , 81 years of age, weighting 167.0 lb, . Potassium dosage: 1 Tablet.
Associated medications used:
  • Ranitidine (1 Tablet)


Respiratory Failure, Tachycardia, Hypertension
Adverse event was reported on Aug 16, 2013 by a Male taking Potassium Chloride (Dosage: N/A) . Location: PT , 62 years of age, Patient felt the following Potassium side effects: respiratory failure, tachycardia, hypertension.
Multiple prescriptions taken:
  • Bupivacaine
  • Bupivacaine
  • Fentanyl
  • Fentanyl


Hyperkalaemia, Bradycardia, Hypotension, Depressed Level Of Consciousness, Acute Respiratory Failure
on Aug 01, 2013 Male from US , 65 years of age, was treated with Potassium Chloride. After Potassium was administered, patient encountered several Potassium side effects: hyperkalaemia, bradycardia, hypotension, depressed level of consciousness, acute respiratory failure. Potassium Chloride dosage: N/A. Patient was hospitalized.

Infusion Site Pain, Vein Disorder, Discomfort
on Jul 26, 2013 Male from US , weighting 317.5 lb, was treated with Potassium Chloride In Sodium Chloride. Directly after, patient experienced the unwanted or unexpected Potassium side effects: infusion site pain, vein disorder, discomfort. Potassium Chloride In Sodium Chloride dosage: 10 Meq/100 Ml.

1 of 37 

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Potassium Side Effects

    Did You Have a Potassium Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Potassium for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    DEXTROSE DEXTROSE, LOSARTAN SODIUM CH

    Active Ingredient: ALLYLTHIO CALCIUM C CALCIUM S CITRIC AC DEXTROSE DEXTROSE; EUPHRASIA HYDROCHLO LOSARTAN LYSINE HY NICKEL SU POTASSIUM

    More About Potassium

    Side Effects reported to FDA: 913

    Potassium safety alerts: 2013 2008

    Reported deaths: 103

    Reported hospitalizations: 274

    20 mEq Potassium Chloride in 5 Percent Dextrose and 0.45 Percent Sodium Chloride Injection, USP

    Audience: Hospital pharmacists, hospital risk managers, other healthcare professionals

    [Posted 12/09/2008] Hospira, Inc. notified healthcare professionals of a recall of one lot (lot number 65-620-FW, expiration date May 1, 2010, NDC 0409-7902-09) of 20 mEq Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP in 1000 mL flexible plastic containers. A small number of the containers may be incorrectly labeled with a bar code for 5% Dextrose Injection, USP (NDC 0409-7922-09). The incorrect bar code could lead to a medication error resulting in the wrong drug being delivered to a patient if a bar code system is used to confirm the medication. Potential adverse events related to an error of this type include electrolyte imbalance, cardiac dysfunction, gastrointestinal disturbances, paresthesia and mental confusion. The affected lot was shipped to U.S. customers between July 2008 and September 2008. Healthcare facilities with an existing inventory should quarantine the product immediately and call Hospira Customer Care at 1-877-946-7747 for instructions on how to return it.

    [December 08, 2008 - Press Release - Hospira, Inc.]

    Latest Potassium clinical trials